Associated Papers
Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates.
Murrey DA et al.
Human Gene Therapy. Clinical Development, 2014
Select a paper to view details